Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David M Jackman, M.D.

Concepts (230)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung42201948652.120 Why?
Quinazolines17201514201.820 Why?
Lung Neoplasms522019121831.790 Why?
Critical Pathways220224601.260 Why?
Mesothelioma420097740.750 Why?
Protein Kinase Inhibitors19201654050.660 Why?
Drug Resistance, Neoplasm10201651970.560 Why?
Pleural Neoplasms220096000.490 Why?
Meningeal Neoplasms2201512210.450 Why?
Antineoplastic Agents152016137140.420 Why?
Decision Support Systems, Clinical1201711550.330 Why?
Tumor Burden7201819060.320 Why?
Peritoneal Neoplasms220095990.300 Why?
Antineoplastic Combined Chemotherapy Protocols82019112530.300 Why?
Adenocarcinoma, Bronchiolo-Alveolar12005920.280 Why?
Genes, erbB-1320101680.270 Why?
Mutation232016292620.270 Why?
ras Proteins2201211160.260 Why?
Biopsy1201667660.260 Why?
Carcinoma, Small Cell120054130.240 Why?
Health Care Costs1201731520.240 Why?
Disease-Free Survival7201670260.240 Why?
Proto-Oncogene Proteins p21(ras)4201516670.240 Why?
Neoplasm Staging152017111260.230 Why?
Proto-Oncogene Proteins c-met220166050.220 Why?
Aged, 80 and over292019581840.200 Why?
Salmon11998340.180 Why?
Neuregulin-1120191410.170 Why?
Feedback120227470.170 Why?
Aged3920191614880.170 Why?
Disease Progression132016132980.170 Why?
Antibodies, Monoclonal3201595840.170 Why?
Proto-Oncogene Proteins2201246770.160 Why?
Middle Aged3920192137520.150 Why?
Adenocarcinoma5201563380.150 Why?
Exons3201624720.150 Why?
Humans6120227088430.150 Why?
Male4620193495240.140 Why?
Inservice Training120184000.140 Why?
Receptor, trkA120151600.140 Why?
Indazoles120152920.130 Why?
Troponin I119986320.130 Why?
Female4020193752050.130 Why?
Neoplasms12022201720.120 Why?
Registries1200979890.120 Why?
Carcinoma, Squamous Cell4201438760.120 Why?
Central Nervous System Neoplasms220128650.120 Why?
Feasibility Studies2201648830.120 Why?
Clinical Trials as Topic1200980240.120 Why?
Tomography, X-Ray Computed102018203080.120 Why?
Smoking4201586120.120 Why?
Medical Oncology2202220980.120 Why?
Maximum Tolerated Dose120159140.110 Why?
Adult3120192110410.110 Why?
Kaplan-Meier Estimate4201767650.110 Why?
Carcinoma, Large Cell120121110.110 Why?
Early Detection of Cancer3201828650.110 Why?
Combined Modality Therapy4201788960.110 Why?
Retrospective Studies222019714830.100 Why?
Mutagenesis, Insertional120136670.100 Why?
Treatment Outcome142016619320.100 Why?
Benzamides1201514060.090 Why?
Neoplastic Cells, Circulating120168620.090 Why?
Nomograms120112250.090 Why?
Survival Analysis42017105070.090 Why?
Survival Rate52018132020.090 Why?
Clinical Trials, Phase II as Topic120126320.090 Why?
Mediastinal Neoplasms120124420.090 Why?
Genotype72015128630.090 Why?
Taxoids120126550.090 Why?
Online Systems120091930.090 Why?
Genes, ras220117190.080 Why?
Oncogene Proteins120127590.080 Why?
Asbestos120091880.080 Why?
Cost-Benefit Analysis2201852350.080 Why?
Pharmacogenetics120126970.080 Why?
Neoplasm Recurrence, Local3201288770.080 Why?
Prognosis82016289190.080 Why?
Polymerase Chain Reaction2201462930.080 Why?
Cone-Beam Computed Tomography120104030.080 Why?
Ketoconazole120061000.080 Why?
DNA, Neoplasm2201617820.080 Why?
Benzimidazoles120128820.080 Why?
Continuity of Patient Care1201310470.070 Why?
Mortality1201727320.070 Why?
DNA Mutational Analysis3201243170.070 Why?
Receptor Protein-Tyrosine Kinases1201216320.070 Why?
Health Personnel1201829830.070 Why?
Molecular Targeted Therapy1201628780.060 Why?
Paraneoplastic Syndromes120051560.060 Why?
Venous Thromboembolism1201615370.060 Why?
Dose-Response Relationship, Drug22015112390.060 Why?
Molecular Imaging120118530.060 Why?
Immunohistochemistry52016117900.060 Why?
Guidelines as Topic1200914180.060 Why?
Cisplatin1200916510.060 Why?
Mass Screening1201851820.060 Why?
Follow-Up Studies62019390380.050 Why?
Angiogenesis Inhibitors1201220670.050 Why?
Iohexol220142050.050 Why?
Electronic Health Records1201841730.050 Why?
Sequence Deletion1200615480.050 Why?
Enzyme Inhibitors1201239360.050 Why?
Sequence Homology, Amino Acid2201329260.050 Why?
In Situ Hybridization, Fluorescence3201226680.050 Why?
Genetic Testing1201433030.050 Why?
Carcinoma1201223070.050 Why?
Intercellular Signaling Peptides and Proteins1200817560.050 Why?
Point Mutation1200616560.050 Why?
Clinical Trials, Phase I as Topic220153300.050 Why?
Randomized Controlled Trials as Topic5201894880.050 Why?
Glycoproteins1200823090.050 Why?
DNA1201471720.050 Why?
Neoplasm Metastasis3201551120.050 Why?
Sirolimus1200715710.050 Why?
Image Enhancement1201129750.050 Why?
Adrenal Insufficiency120011700.050 Why?
Atlantic Ocean11998190.050 Why?
Risk Factors82018695530.040 Why?
Receptor, erbB-3120191250.040 Why?
Treatment Failure2201526800.040 Why?
Prospective Studies42016505970.040 Why?
Databases, Factual2201477630.040 Why?
Disease Models, Animal22012183750.040 Why?
Incidence42016203200.040 Why?
Radiographic Image Enhancement220149240.040 Why?
Cell Proliferation12013108030.040 Why?
Nuclear Proteins1201259820.040 Why?
Sepsis2200124490.040 Why?
Brain Neoplasms2201487760.040 Why?
Head and Neck Neoplasms1200825910.030 Why?
Age Factors22016187120.030 Why?
Efficiency120184870.030 Why?
Self Efficacy120186290.030 Why?
Young Adult52015559400.030 Why?
Evaluation Studies as Topic1201617460.030 Why?
Cell-Free System120143700.030 Why?
Amino Acid Sequence22013142150.030 Why?
Sequence Analysis, DNA2201049260.030 Why?
Intestine, Small1199912350.030 Why?
Practice Guidelines as Topic1201074870.030 Why?
Reproducibility of Results32018194230.030 Why?
Muscle Proteins1199812380.030 Why?
Amino Acids1199817520.030 Why?
Cloning, Molecular1199844890.030 Why?
Guanine120132830.030 Why?
Bacterial Infections1200114230.030 Why?
Glutamates120134060.030 Why?
Molecular Sequence Data22013187480.030 Why?
Organoplatinum Compounds120134310.030 Why?
Plasma120145730.020 Why?
Gene Rearrangement1201512020.020 Why?
Genes, p53120127640.020 Why?
Area Under Curve1201416880.020 Why?
Mitogen-Activated Protein Kinase Kinases120126030.020 Why?
Program Evaluation1201825240.020 Why?
Withholding Treatment120135800.020 Why?
Contrast Media2201452670.020 Why?
Punctures220013720.020 Why?
AMP-Activated Protein Kinases120126150.020 Why?
Cohort Studies32016392920.020 Why?
Medical History Taking120128040.020 Why?
Adrenal Gland Neoplasms120147310.020 Why?
Ligands1201532970.020 Why?
Endpoint Determination120116230.020 Why?
Predictive Value of Tests22016152520.020 Why?
Propensity Score1201417150.020 Why?
Radiographic Image Interpretation, Computer-Assisted1201512340.020 Why?
Statistics, Nonparametric1201329450.020 Why?
Lung2201997060.020 Why?
Drug Evaluation, Preclinical1201213990.020 Why?
Patient Selection1201943060.020 Why?
In Situ Hybridization1201019880.020 Why?
ROC Curve1201435180.020 Why?
Pyrazoles1201619540.020 Why?
Cell Line, Tumor22015169590.020 Why?
Analysis of Variance1201465300.020 Why?
Cytokines1199971890.020 Why?
MAP Kinase Signaling System1201215880.020 Why?
Observer Variation1201026870.020 Why?
Neoadjuvant Therapy1201525610.020 Why?
Attitude of Health Personnel1201838850.020 Why?
Prostatic Neoplasms12006105250.020 Why?
Adolescent22009847180.020 Why?
Mutation, Missense1201325030.020 Why?
Neoplasms, Hormone-Dependent120064140.020 Why?
Pyridines1201628620.020 Why?
Fluorodeoxyglucose F181201219880.010 Why?
Radiography1201469890.010 Why?
Massachusetts1201587120.010 Why?
High-Throughput Nucleotide Sequencing1201537080.010 Why?
Bone Neoplasms1201425790.010 Why?
Cecum120012350.010 Why?
Protein-Tyrosine Kinases1201024610.010 Why?
Corticosterone120013140.010 Why?
Recurrence1201282550.010 Why?
Animals520121704860.010 Why?
Ligation120014810.010 Why?
Genetic Predisposition to Disease22012172180.010 Why?
Protein Kinases1200716800.010 Why?
Neoplasm Proteins1201237730.010 Why?
Adrenocorticotropic Hormone120016320.010 Why?
Fatigue1200614500.010 Why?
Sodium Chloride120016400.010 Why?
Adrenal Glands120015410.010 Why?
Prevalence12015147120.010 Why?
TOR Serine-Threonine Kinases1200721180.010 Why?
Antineoplastic Agents, Hormonal1200615210.010 Why?
Prostate-Specific Antigen1200622450.010 Why?
Imaging, Three-Dimensional1201039840.010 Why?
Multivariate Analysis12011124470.010 Why?
Image Processing, Computer-Assisted1201489680.010 Why?
Cyclic AMP1200115300.010 Why?
Proportional Hazards Models12011122920.010 Why?
Risk Assessment12018232840.010 Why?
Severity of Illness Index12014160080.010 Why?
Interleukin-11199912760.010 Why?
Positron-Emission Tomography1201261700.010 Why?
Gene Expression Regulation, Neoplastic1201186380.010 Why?
Sensitivity and Specificity12010148360.010 Why?
Rats22001250940.010 Why?
Reverse Transcriptase Polymerase Chain Reaction1199949410.010 Why?
United States12018671650.010 Why?
Up-Regulation1199943530.010 Why?
Interleukin-61199931790.010 Why?
Rats, Sprague-Dawley1200185930.010 Why?
Tumor Necrosis Factor-alpha1199944660.010 Why?
Gene Expression1199980140.000 Why?
Mice12012808760.000 Why?
Time Factors12001410380.000 Why?
Jackman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (230)
Explore
_
Co-Authors (66)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.